Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery

Abstract

The aim of the study was to assess the effect of aspirin or heparin pretreatment on platelet function and bleeding in the early postoperative period after coronary artery bypass grafting (CABG) surgery.

Seventy-five male patients with coronary artery disease who underwent CABG with cardiopulmonary bypass (CPB) were studied. The patients were divided into three groups: Group 1 (n = 25) included patients receiving aspirin pretreatment, Group 2 (n = 22) received heparin pretreatment, and Group 3 (n = 28) included patients who received no antiplatelet or anticoagulant pretreatment. Twenty-four hours after surgery, all patients were administered aspirin therapy that was continued throughout their hospitalization period. We assessed the following preoperative blood coagulation indices: activated partial thromboplastin time (aPTT), international normalized ratio (INR), and fibrinogen. We compared platelet count and platelet aggregation induced by adenosinediphosphate (ADP) before surgery, 1 h after surgery, 20 h after surgery and on the seventh postoperative day. We assessed drained blood loss within 20 postoperative hours.

Preoperative blood coagulation indices did not differ among the groups. Platelet count was also similar. One hour after surgery, platelet count significantly decreased in all groups (p <0.001), after 20 postoperative hours it did not undergo any marked changes, and on the seventh postoperative day, it significantly increased in all groups (p <0.001). Before surgery, the lowest index of ADP-induced platelet aggregation was found in Group 1 (p <0.05). One hour after surgery, platelet aggregation significantly decreased in all groups, most markedly in Group 3 (p <0.001), yet after 20 h, its restitution tendency and a significant increase in all groups was noted. On the seventh day, a further increase in the statistical mean platelet aggregation value was noted in Groups 2 and 3. Comparison of platelet aggregation after 20 postoperative hours and on the seventh day after surgery revealed a significantly higher than 10% increase of the index in 32% of patients in Group 1 (p <0.05), 27.3% of patients in Group 2 (p <0.05) and in 35.7% of patients in Group 3 (p <0.001). The lowest statistically significant value of postoperative blood loss was noted in Group 2 (p <0.01).

Our study has shown that aspirin or heparin pretreatment had no impact on the dynamics of platelet function in the early postoperative period after CABG. The lowest postoperative blood loss was noted in patients pretreated with heparin.

Keywords

aspirin heparin platelet aggregation coronary artery bypass surgery

Get full access to this article

View all access options for this article.

References

Harrington RA , Becker RC , Ezekowitz M et al. Antithrombotic therapy for coronary artery disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest 2004; 126: 513S-48S .

Merritt JC , Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy . J Thromb Thrombolysis 2002; 13: 97-103 .

Weber A-A , Zimmermann K. Cyclooxygenase-2 in human platelets as possible factor in aspirin resistance . Lancet 1999; 353: 900-900 .

Patrono C , Coller B , Fitzgerald GA et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest 2004; 126: 234S-264S .

Fatah K , Beving H , Albage A et al. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity . Is withdrawing of treatment harmful to the patient? Eur Heart J 1996; 17: 1362-1366 .

Collet JP , Montalescot G , Blanchet B et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes . Circulation 2004; 110: 2361-2367 .

Ferrari E , Benhamou M , Cerboni P , Baudouy M. Coronary syndromes following aspirin withdrawal. A special risk for late stent thrombosis . J Am Coll Cardiol 2005; 45(3): 456-459 .

Samama CM , Bastien O , Forestier F et al. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001. http://www.sfar.org/pdf/aapconfexp2.pdf

Despotis GJ , Gravlee G , Filos K , Levy J. Anticoagulation monitoring during cardiac surgery . Anesthesiology 1999; 91: 4-18 .

10.

De Haan J , Boonstra PW , Monnink SH et al. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis . Ann Thorac Surg 1995; 59: 901-907 .

11.

Despotis GJ , Hogue CW. Pathophysiology, prevention and treatment of bleeding after cardiac surgery: a primer for cardiologists and an update for the cardiothoracic team . Am J Cardiol 1999; 83: 15B-30B .

12.

Hardy JF , Belisle S , Janvier G , Samama M. Reduction in requirements for allogeneic blood products: nonpharmacologic methods . Ann Thorac Surg 1996; 62: 1935-1943 .

13.

Michelson AD , MacGregor H , Barnard MR et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro . Thromb Haemost 1994; 71: 633-640 .

14.

Christenson JT , Gras PA , Grosclaude A et al. Reactive thrombocytosis following coronary artery bypass surgery: a possible link to a lipid dysfunction . J Cardiovasc Surg 1996; 37: 491-498 .

15.

Schmuziger M , Cristenson JT , Maurice J et al. Reactive thrombocytosis after coronary bypass surgery. An important risk factor . Eur J Cardiothorac Surg 1995; 9: 393-398 .

16.

Friend M , Vucenik I , Miller M. Platelet responsiveness to aspirin in patients with hyperlipidaemia . BMJ 2003; 326: 82-83 .

17.

Zimmermann N , Wenk A , Kim U et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery . Circulation 2003; 108: 542-547 .

18.

Zimmermann N , Kienzle P , Weber A-A et al. Aspirin resistance after coronary artery bypass grafting . J Thorac Cardiovasc Surg 2001; 121: 982-984 .

19.

Kurth T , Glynn RJ , Walker AM et al. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs . Circulation 2003; 108: 1191-1195 .

20.

Catella-Lawson F , Reilly MP , Kapoor SC et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin . N Engl J Med 2001; 345: 1809-1817 .

21.

Brinks HJ , Weerwind PW , Bogdan S et al. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass ? Perfusion 2001; 16: 3-12 .

22.

Grubitzsch H , Wollert H-G , Eckel L. Emergency coronary artery bypass grafting: does excessive preoperative anticoagulation increase bleeding complications and transfusion requirements ? Cardiovasc Surg 2001; 9: 510-516 .